Product Browser

Last updated: 2016/12/4

Product Compare

Product Compare Cancel Click this icon to add products to compare list. Select up to 10 products.

Quick Order (Tutorial)

Input Catalog #,
place order here!
Catalog # :
  • Where to buy
  • Choose your location

RAET1E 293T Cell Transient Overexpression Lysate(Denatured)

  • Catalog # : H00135250-T01
  • Visit Frequency :
  • Countries :
  • Specification
  • Transfected Cell Line:
  • 293T
  • Plasmid:
  • pCMV-RAET1E full-length
  • Host:
  • Human
  • Theoretical MW (kDa):
  • 30.1
  • Quality Control Testing:
  • Transient overexpression cell lysate was tested with Anti-RAET1E antibody (H00135250-B01) by Western Blots.
    SDS-PAGE Gel
    QC Testing of H00135250-T01
    RAET1E transfected lysate.
    Western Blot
    QC Testing of H00135250-T01
    Lane 1: RAET1E transfected lysate ( 30.1 KDa)
    Lane 2: Non-transfected lysate.
  • Storage Buffer:
  • 1X Sample Buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 300 mM 2-mercaptoethanol, 0.01% Bromophenol blue)
  • Storage Instruction:
  • Store at -80°C. Aliquot to avoid repeated freezing and thawing.
  • Applications
  • Western Blot
  • Application Image
  • Western Blot
  • Gene Information
  • Gene Name:
  • RAET1E
  • Gene Alias:
  • LETAL,MGC125308,MGC125309,RAET1E2,ULBP4,bA350J20.7
  • Gene Description:
  • retinoic acid early transcript 1E
  • Gene Summary:
  • Members of the RAET1 family, such as RAET1E, are major histocompatibility complex (MHC) class I-related genes located within a 180-kb cluster on chromosome 6q24.2-q25.3. RAET1 proteins contain MHC class I-like alpha-1 and alpha-2 domains. RAET1E and RAET1G (MIM 609244) differ from the other RAET1 proteins (e.g., RAET1I, or ULBP1; MIM 605697) in that they have type I membrane-spanning sequences at their C termini rather than glycosylphosphatidylinositol anchor sequences. (Radosavljevic et al., 2002 [PubMed 11827464]).[supplied by OMIM
  • Other Designations:
  • OTTHUMP00000017404,lymphocyte effector toxicity activation ligand
  • RSS
  • YouTube
  • Linkedin
  • Facebook